Winton Group LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$58.09 - $82.51 $350,282 - $497,535	-6,030 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$58.38 - $84.96 $85,701 - $124,721	1,468 Added 32.18%	6,030 $376,000
Q2 2021 Aug 10, 2021	BUY	$62.15 - $90.32 $283,528 - $412,039	4,562 New	4,562 $378,000
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $1.72 Million - $5.28 Million	-83,709 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $2.36 Million - $6.11 Million	83,709 New	83,709 $5.31 Million
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $363,333 - $482,322	-13,836 Closed	0 $0
Q2 2019 Jul 08, 2019	BUY	$17.43 - $28.82 $241,161 - $398,753	13,836 New	13,836 $367,000
Q1 2019 May 13, 2019	SELL	$12.05 - $20.18 $190,968 - $319,812	-15,848 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$10.74 - $19.7 $170,207 - $312,205	15,848 New	15,848 $197,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.